Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Primitif du foie
- | Specialty :
- Thérapies Ciblées
Extract
A randomized, double-blind, multicenter phase III study of brivanib versus placebo as adjuvant therapy to trans-arterial chemo-embolization (TACE) in patients with unresectable hepatocellular carcinoma (the BRISK TA study).
Scientific Abstract
en cours d'intégration;